Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT06932861
EARLY_PHASE1
Exploratory Study of Personalized mRNA Vaccine in Patients With Refractory Rhabdomyosarcoma
Sponsor: Xinxin Zhang
View on ClinicalTrials.gov
Summary
An Exploratory Study on the Use of mRNA Tumor Vaccines in the Treatment of Refractory Rhabdomyosarcoma
Key Details
Gender
All
Age Range
6 Years - Any
Study Type
INTERVENTIONAL
Enrollment
5
Start Date
2025-05-01
Completion Date
2028-05-01
Last Updated
2025-04-22
Healthy Volunteers
No
Conditions
Interventions
BIOLOGICAL
mRNA Tumor Vaccine Therapy
personalized mRNA vaccines